Johnson Anne Nagengast — SEC Form 4 filings
SEC reporting owner CIK 1976640. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-15 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 60,955 shares, $95,994 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 27,410 shares @ $1.85 ($50,708) in ATAI Life Sciences N.V., filed 2024-04-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ATAI Life Sciences N.V. (ATAI) | Chief Financial Officer | 6 | — | 2 legs · 60,955 sh · $95,994 | 10 |
| AtaiBeckley Inc. (ATAI) | Chief Accounting Officer | 2 | — | — | 11 |
Form 4 filings — Johnson Anne Nagengast
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | AtaiBeckley Inc. (ATAI) | Disposition to issuer (D): 140,045 · Disposition to issuer (D): 326,416 (derivative) · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 71,620 (derivative) · Disposition to issuer (D): 500,000 (derivative) · Disposition to issuer (D): 550,000 (derivative) · +3 more | EDGAR |
| 2026-02-03 | 4 | AtaiBeckley Inc. (ATAI) | Grant/award (A): 525,000 (derivative) @ $0 · Grant/award (A): 117,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | ATAI Life Sciences N.V. (ATAI) | Sale (S): 33,545 @ $1.35 | EDGAR |
| 2025-03-19 | 4 | ATAI Life Sciences N.V. (ATAI) | Option exercise (M): 100,000 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | ATAI Life Sciences N.V. (ATAI) | Grant/award (A): 757,915 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | ATAI Life Sciences N.V. (ATAI) | Disposition to issuer (D): 326,416 (derivative) · Disposition to issuer (D): 115,152 (derivative) · Grant/award (A): 326,416 (derivative) · Grant/award (A): 115,152 (derivative) | EDGAR |
| 2024-04-04 | 4 | ATAI Life Sciences N.V. (ATAI) | Sale (S): 27,410 @ $1.85 | EDGAR |
| 2024-03-15 | 4 | ATAI Life Sciences N.V. (ATAI) | Option exercise (M): 100,000 · Grant/award (A): 550,000 (derivative) @ $0 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1976640 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →